Vertex Pharmaceuticals Incorporated (VRTX)
VRTX Income statement
VRTX Balance sheet
VRTX Key balance sheet metrics
VRTX Cash flow statement
VRTX Key cash flow statement metrics
Discover more VRTX fundamentals
FAQ
What are Vertex Pharmaceuticals Incorporated (VRTX) Key Income Statement Metrics?
As of today, Vertex Pharmaceuticals Incorporated last 12-month Revenue is $10.3B , EBITDA is ($0.0B) and Net Income is ($0.5B) , based on the financial report for Jun 30, 2024 (Q2 2024).
What are Vertex Pharmaceuticals Incorporated (VRTX) Key Balance Sheet Metrics?
As of today, Vertex Pharmaceuticals Incorporated Total Assets are $20.1B and Total Liabilities are $5.4B , based on the financial report for Jun 30, 2024 (Q2 2024).
What are Vertex Pharmaceuticals Incorporated (VRTX) Key Cash Flow Statement Metrics?
As of today, Vertex Pharmaceuticals Incorporated last 12-month Cash Flow from Operating Activities is ($3,753,600,000.0), Cash Flow from Investing Activities is ($463,700,000.0) and Cash Flow from Financing Activities is ($358,600,000.0), based on the financial report for Jun 30, 2024 (Q2 2024).
What is Vertex Pharmaceuticals Incorporated (VRTX) Free Cash Flow?
As of today, Vertex Pharmaceuticals Incorporated last 12-month Free Cash Flow is ($1,425.8M) , based on the financial report for Jun 30, 2024 (Q2 2024).